Purchase Order 75N93019P00026
Award Date 1/3/19
Potential Completion Date 1/2/20
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents, for maintenance on a MiSeq sequencer. The potential value of the contract is $12,875.00. There was no set-aside designation for this contract. Illumina has received prior federal contract awards from agencies like the NIH,...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and consumables. The contract is for service and maintenance of an Illumina MiSeq system for fiscal year 2021, with a total ceiling value of $14,070.00. The contract has no set-aside designation. Illumina has received numerous prior federal...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of a MiSeq System sequencing platform. The contract has a ceiling value of $95,931.00 and a completion date of August 21, 2014. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously provided such products and services to various federal...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the maintenance of an Illumina MiSeq sequencer used for immunology and inflammation research. The contract has a ceiling value of $16,198.00 and a period of performance through May 26, 2026. Illumina, a leading manufacturer of genetic sequencing and genomic analysis technologies, has been...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of a MiSeq benchtop DNA sequencer system. The total ceiling value of the contract is $119,937.50, with a performance period ending on December 2, 2013. The contract does not have any set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing systems and analytical instruments. The $7,902 contract is for comprehensive service and support for Illumina's MiSeq gene and small genome sequencer. The award has no set-aside designation and is not associated with a larger contract vehicle. Illumina has been awarded...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq and NextSeq maintenance service agreement. The contract has a ceiling value of $54,252.56 and a performance period ending on March 24, 2030. Illumina is a manufacturer of genetic sequencing systems and related consumables. The award does not utilize any small business set-asides....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger...